SciELO - Scientific Electronic Library Online

 
vol.116 número2Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsyDirect-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/ Groote Schuur Hospital Liver Clinic, South Africa índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

    Links relacionados

    • En proceso de indezaciónCitado por Google
    • En proceso de indezaciónSimilares en Google

    Compartir


    SAMJ: South African Medical Journal

    versión On-line ISSN 2078-5135versión impresa ISSN 0256-9574

    Resumen

    MAPONGA, T G; ANDERSSON, MI  y  PREISER, W. When will South Africa take the prevention of chronic HBV infection seriously?. SAMJ, S. Afr. med. j. [online]. 2026, vol.116, n.2, pp.20-21. ISSN 2078-5135.  https://doi.org/10.7196/SAMJ.2026v116i2.3771.

    South Africa (SA) bears a significant burden of hepatitis B virus (HBV) infection, with a significant prevalence of hepatitis B surface antigen (HBsAg) among pregnant women. In response, the National Department of Health has recommended targeted birth-dose vaccination for infants born to HBsAg-positive mothers. While we commend the move towards antenatal HBsAg screening to identify infected pregnant women, we reiterate that a universal HBV birth-dose vaccination strategy would be a simpler, more equitable and more effective approach to preventing vertical transmission and reducing the overall HBV burden in SA.

    Palabras clave : hepatitis B virus; birth-dose vaccine; mother-to-child transmission.

            · texto en Inglés     · Inglés ( pdf )